IP Library Granted Patent US 8,568,403
Granted Patent B2
US 8,568,403 · App. 12/606,007 · Granted Oct 29, 2013

Selective lung tissue ablation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,568,403
App. No.
12/606,007
Granted
Oct 29, 2013
Kind
B2
Abstract

Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.

Claims (12)

1. A method for selectively ablating a treatment region in a lung comprising:

advancing a treatment apparatus through an airway toward the treatment region in the lung; and

exchanging energy through the treatment apparatus to heat or cool the treatment region to a level which destroys tissue at the region; and

protecting adjacent regions in the lung and surrounding tissue from thermal damage by controlling pressure and temperature simultaneously at the treatment region and at one or more untreated regions adjacent the treatment region so that thermal damage to the untreated regions is minimized, wherein the exchanged energy induces tissue necrosis followed by the collapse of the treatment region.

2. A method as in claim 1 , where exchanging energy heats tissue to a temperature in the range from 40′C to 95° C.

3. A method as in claim 1 , wherein the exchanged energy comprises radio frequency, alternating current, microwave, ultrasound, coherent light, incoherent light, radioisotopes, or any combination of these.

4. A method as in claim 1 , wherein the exchanged energy comprises thermal energy generated from a resistive coil or a hot fluid element.

5. A method as in claim 1 , wherein the treatment region comprises a lobe or segment of the lung.

6. A method as in claim 5 , wherein the untreated regions adjacent the treatment region comprises an adjacent lobe or segment of the lung.

7. A method as in claim 1 , wherein protecting adjacent regions comprises ventilating or pressurizing the adjacent region with a cooler gas or liquid.

8. A method as in claim 7 , wherein the cooler gas or liquid comprises cooled air cooled oxygen, cooled saline, or a cooled perfluorocarbon.

9. A method as in claim 7 , wherein the cooler gas is delivered via the treatment apparatus.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2015
From: SOLTESZ, PETER P.; ALJURI, NIKOLAI; NAIR, AJIT
To: PULMONX
Reel/Frame 035725/0881 →